NASDAQ · Biotechnology

Abpro Corporation (ABP) Stock

$0.52 NASDAQ: ABP Healthcare

Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry.

Valuation

MetricValue
Price$0.52
Market Cap$1.06M
P/E Ratio-0.02
P/B Ratio—
P/S Ratio3.22
EPS (TTM)$-23.10
52-Week High$18.03
52-Week Low$0.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE46.67%
ROA-140.00%
ROCE102.05%
Gross Margin-55.19%
Operating Margin-79.51%
Net Margin-76.70%
Debt/Equity-0.01
Current Ratio0.20

Annual Financials (USD)

Metric20172021202220232024
Revenue$2.0M$0$2.0M$0$0
Operating Profit$-12.0M$-15.0M$-17.0M$-12.0M$-10.0M
Net Profit$-12.0M$-15.0M$-17.0M$-12.0M$-7.0M
EPS$-31.50$-47.70$-55.50$-37.50$-23.10
Op Margin-561.4%-3120.2%-822.3%-9627.9%-5421.3%

Balance Sheet (USD)

Metric20172021202220232024
Total Assets$17.0M$8.0M$12.0M$3.0M$5.0M
Total Liabilities$40.0M$5.0M$88.0M$88.0M$20.0M
Cash$15.0M$7.0M$7.0M$1.0M$3.0M
Borrowings$0$1.0M$2.0M$3.0M$3.0M

Latest News

New Mideast fighting puts eurozone rate-setters on alert AFP · Jul 23, 2026 Dow Jones Futures Rise; Google, Tesla Fall On Earnings, Capex, But AI Stocks Climb Investor's Business Daily · Jul 23, 2026 What's the deal with peptides? The hyped market under US review AFP · Jul 23, 2026 TowneBank Reports Second Quarter 2026 Earnings GlobeNewswire · Jul 23, 2026 Pichai pushes back on claims Google is losing ground in AI race Reuters · Jul 23, 2026

Cash Flow (USD)

Metric20172021202220232024
Operating Cash Flow$-9.0M$-11.0M$-9.0M$-7.0M$-9.0M
Investing Cash Flow$-2.0M$0$0$0$0
Financing Cash Flow$18.0M$0$0$0$-2.0M
Net Cash Flow$7.0M$7.0M$1.0M$-7.0M$2.0M
Free Cash Flow$-10.0M$-11.0M$-9.0M$-7.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA—
FCF Yield-2313.43%
Quick Ratio0.07
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AEONAEON Biopharma, Inc. $0.24 -5.50% -0.05 $2.80M 0.00%
APM $0.81 -0.78% -4.42 $5.15M 0.00%
BOLT $3.95 -0.50% -0.26 $7.59M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%
CLRB $2.37 -2.07% -0.38 $7.57M 0.00%

About Abpro Corporation

Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.

Abpro Corporation (ABP) stock trades at $0.52 with a market capitalization of $1.06M. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-sales of 3.22. Over the past 52 weeks the stock has ranged between $0.11 and $18.03, and currently trades 97.1% below its 52-week high.

On profitability, Abpro Corporation generates a return on equity (ROE) of 46.67% — well above the market average, a sign of a high-quality business, return on capital employed of 102.05%, an operating margin of -79.51%, a net profit margin of -76.70%.

Official website: abpro.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides